What the BDNF Gene Variant rs6265 Means for Memory and Mood

If you carry the Met version of BDNF rs6265, your brain makes a slightly different, less efficiently secreted form of a protein called brain-derived neurotrophic factor. I've spent a chunk of the past few weeks reading the papers on this one, and here's the short version: that single amino acid swap, valine to methionine at position 66, is tied in multiple studies to faster memory decline, lower hippocampal volume, and altered emotional memory. It's not a diagnosis. It's one variant among thousands that shape how your brain adapts, and the evidence for it is real but still uneven. I'll show you exactly where it's solid and where it isn't.

What BDNF actually does in your brain

BDNF stands for brain-derived neurotrophic factor. I think of it as fertilizer for neurons, and that's basically what it is. It helps brain cells grow new connections, strengthen the ones they already have, and survive stress that would otherwise kill them off. This process, neuroplasticity, is how you learn a new skill or recover a memory after sleep. Without enough BDNF circulating in the right places, that whole process gets sluggish.

The hippocampus, your brain's memory-indexing region, depends heavily on it. So do circuits involved in fear extinction and emotional regulation. That's part of why researchers keep circling back to BDNF whenever they study mood and trauma.

The Val66Met switch: what rs6265 changes

The gene that codes for BDNF has a common variant at position rs6265, known as Val66Met. Everyone gets two copies, one from each parent: Val/Val, Val/Met, or Met/Met. The Met version doesn't just change the protein a little. I dug into a 2023 Frontiers in Neurology study out of Aligarh Muslim University, and it states plainly that "the Val66Met polymorphism (rs6265) of the BDNF gene causes a decrease in BDNF secretion and plays a role in impairments in cognition, energy homeostasis," among other traits. That's the mechanism in one sentence: less BDNF getting released where and when the brain needs it.

Met carriers aren't rare, by the way. Depending on the population studied, a meaningful share of people carry at least one copy. What differs is what that copy actually seems to do once it's there.

What the memory research actually shows

Here's where it gets interesting, and where the honesty matters most. There's a 2022 review in Neural Regeneration Research, led by researchers at Western Kentucky University, that I keep coming back to. It found Met66 carriers had memory decline roughly four times faster than Val66 carriers, alongside hippocampal volume loss and cerebrospinal fluid markers of tau and phosphorylated tau (ptau181) running about six times higher. Sit with that for a second. Those are striking numbers for a single gene variant. They come from work synthesizing BDNF's role across neurodegeneration research broadly, not one small trial, which is part of why the paper frames rs6265 as a "master modifier" of brain pathophysiology rather than a footnote.

Separately, I found a 2021 Saudi Pharmaceutical Journal study out of King Saud University that looked at Val66Met in Arab Alzheimer's disease patients. It found the genotype had "significant association with cognitive performance in both elderly control group and AD" patients, including those on SSRIs. Two different research groups. Two different populations. Both pointing the same direction on memory. That's a decent signal, and I don't want to undersell it. But it is not proof that any one person's genotype determines their cognitive fate. It doesn't work that way.

Mood, PTSD, and emotional memory: the mixed part

The science gets genuinely murky here, and I'd rather tell you that straight than smooth it over. A 2023 Scientific Reports study from the University of Melbourne examined how Val66Met affects emotional recognition memory in people with PTSD. The researchers say upfront that "the BDNF Val66Met polymorphism has been associated with PTSD risk and memory deficits respectively, although findings have been inconsistent, potentially due to" differences in study design and populations.

Read that twice. A peer-reviewed 2023 paper on the exact question of BDNF and trauma-related memory is telling you the field's own findings don't agree with each other. That's not a knock on the gene. It's a statement about how hard mood and trauma research is to pin to a single variant, when stress history, other genes, and environment all pile on top of each other.

Beyond memory: IQ, BMI, and blood pressure

BDNF's reach goes well beyond memory and trauma, which surprised me when I first saw it. The same Frontiers in Neurology genetic association study out of North India tested rs6265 against three unrelated traits at once: intelligence quotient, body mass index, and blood pressure. That the researchers bothered to test all three together tells you something. In the literature, BDNF carries fingerprints on metabolism and cardiovascular regulation, beyond memory alone. Part of the reason: BDNF signaling touches appetite and energy balance in the hypothalamus, plus the hippocampus.

What about exercise?

You'll see BDNF mentioned constantly in fitness and biohacking content as "the molecule behind the runner's high," or the reason cardio sharpens your memory. Look, the underlying biology here, BDNF rising with aerobic activity, is well established in exercise physiology research generally. But none of the four studies behind this post measured exercise response by rs6265 genotype directly. So I'm not going to hand you a number that isn't there. If that angle interests you, treat it as a separate, actively studied question rather than an extension of the memory findings above.

Where this fits on a DNA test

Biome's DNA panel reports on a trait it calls "Neuroplasticity" using the BDNF rs6265 marker, at what Biome classifies as a moderate evidence tier. That tier matters more than the marker name does. Moderate means the biology is well described and multiple studies point the same way on some outcomes, like memory decline in the research above, while other outcomes, like PTSD-related memory, still show inconsistent results across studies. It's not the same as a marker where a hundred replicated trials all agree.

A result on a report like this is a data point about population-level associations applied to your genotype. It's not a memory test. It's not a mood diagnosis. What you actually do with sleep, exercise, stress, and treatment when needed still matters more day to day than one variant does.

One more thing, and it's a company-agnostic point, not a Biome-specific claim: how any DNA testing company stores, uses, or shares your genetic data is a separate question from what the science says about a gene. Reputable testing companies typically publish a specific privacy policy covering retention and data sharing. Read the actual policy of whichever company you're considering, Biome or otherwise, before you spit in a tube.

FAQ

Does the BDNF Met allele mean I'll get dementia? No. Carrying one or two Met copies is associated with faster memory decline and more hippocampal volume loss in the Neural Regeneration Research review, but an association across a study population isn't the same as an individual prediction or a diagnosis.

Is Val66Met the same thing as rs6265? Yes. Val66Met is the name for the amino acid change, and rs6265 is the specific reference SNP ID for that same variant in the BDNF gene, used across both the Frontiers in Neurology and Saudi Pharmaceutical Journal studies I cited above.

Does BDNF genotype affect antidepressant or SSRI response? Some evidence points that way. The Saudi Pharmaceutical Journal study looked at Val66Met alongside SSRI use in Alzheimer's patients and found a genotype link to cognitive performance in that group. Worth flagging, though: that's one study in one specific patient population, not a general rule for antidepressant response.

Why do studies on BDNF and mood disagree with each other? The Scientific Reports authors point to inconsistent findings across the PTSD and memory-deficit literature, likely driven by differences in study design and the populations studied. Mood and trauma involve many genes and a lot of environmental input, so one variant rarely tells the whole story.

Should I get tested for BDNF rs6265? Depends what you're looking for, honestly. It's one marker among many on a broader panel like the one Biome offers, useful as context about neuroplasticity-related biology rather than a standalone answer about your memory or mental health.